Cargando…
Synergistic inhibitory effects of deferasirox in combination with decitabine on leukemia cell lines SKM-1, THP-1, and K-562
A multi-center study from the French Myelodysplastic Syndrome (MDS) Group confirmed that iron chelation therapy is an independent prognostic factor that can increase the survival rate of patients who are suffering from transfusion-dependent low-risk MDS. In this study, we aimed to explore this clini...
Autores principales: | Li, Nianyi, Chen, Qinfen, Gu, Jingwen, Li, Shuang, Zhao, Guangjie, Wang, Wei, Wang, Zhicheng, Wang, Xiaoqin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5482673/ https://www.ncbi.nlm.nih.gov/pubmed/28388554 http://dx.doi.org/10.18632/oncotarget.16583 |
Ejemplares similares
-
Synergistic Effect and Molecular Mechanism of Homoharringtonine and Bortezomib on SKM-1 Cell Apoptosis
por: Zhang, Jing, et al.
Publicado: (2015) -
Decitabine-Induced Changes in Human Myelodysplastic Syndrome Cell Line SKM-1 Are Mediated by FOXO3A Activation
por: Zeng, Wen, et al.
Publicado: (2017) -
High methylation of the 4-aminobutyrate aminotransferase gene predicts a poor prognosis in patients with myelodysplastic syndrome
por: Zhao, Guangjie, et al.
Publicado: (2018) -
The Efficacy and Safety of Vitamin C for Iron Supplementation in Adult Patients With Iron Deficiency Anemia: A Randomized Clinical Trial
por: Li, Nianyi, et al.
Publicado: (2020) -
In Vitro Evaluation of Two Novel Antimalarial Derivatives of SKM13: SKM13-MeO and SKM13-F
por: Trinh, Thuy-Tien Thi, et al.
Publicado: (2022)